Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Annals of Intensive Care|September 21, 2020
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative reviewYasser Sakr, Manuela Giovini, Marc Leone, et al.
Critical Care (London, England)|August 27, 2024
Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysisTommaso Tonetti, Rossana Di Staso, Laura Bambini, et al.
Critical Care (London, England)|May 1, 2015
Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trialPedro Póvoa, Jorge I F Salluh, Maria L Martinez, et al.
Critical Care Medicine|February 25, 2009
Pulmonary atelectasis during low stretch ventilation: "open lung" versus "lung rest" strategyVito Fanelli, Luciana Mascia, Valeria Puntorieri, et al.
Intensive Care Medicine|February 16, 2006
An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) studyCharles L Sprung, Yasser Sakr, Jean-Louis Vincent, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 16, 2019
Feasibility of lung microdialysis to assess metabolism during clinical ex vivo lung perfusionAnna Teresa Mazzeo, Vito Fanelli, Massimo Boffini, et al.
Critical Care (London, England)|April 24, 2007
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic reviewDinna N Cruz, Mark A Perazella, Rinaldo Bellomo, et al.
Intensive Care Medicine|June 10, 2010
Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancyVincenzo Squadrone, Massimo Massaia, Benedetto Bruno, et al.
The Breast Journal|May 12, 2001
Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsyI Méndez, F J Andreu, E Sáez, et al.
Trials|November 15, 2017
Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trialGeoff Bellingan, David Brealey, Jordi Mancebo, et al.
Pageof 21